Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary function in Parkinson's disease.

A Hovestadt1, J M Bogaard, J D Meerwaldt

  • 1Department of Neurology, University Hospital Dijkzigt, Erasmus University, Rotterdam, The Netherlands.

Journal of Neurology, Neurosurgery, and Psychiatry
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of electrodiagnosis in the Dutch Guillain-Barré study.

European journal of neurology·2013
Same author

A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

[Dopamine dysregulation syndrome in a patient with Parkinson's disease; a case report].

Tijdschrift voor psychiatrie·2010
Same author

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

European journal of cancer (Oxford, England : 1990)·2003
Same author

Modeling of the expiratory flow pattern of spontaneously breathing cats.

Respiratory physiology & neurobiology·2003
Same author

Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness.

Thorax·2002

Parkinson's disease patients often have subclinical upper airway obstruction and reduced muscle strength, impacting pulmonary function. These findings highlight the need for early respiratory assessments in Parkinson's disease management.

Area of Science:

  • Neurology
  • Pulmonology
  • Respiratory Medicine

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder affecting motor control.
  • Respiratory complications are common in PD patients, impacting quality of life.
  • Subclinical respiratory dysfunction may precede overt symptoms in PD.

Purpose of the Study:

  • To investigate pulmonary function in patients with relatively severe Parkinson's disease.
  • To identify potential subclinical respiratory abnormalities, including upper airway obstruction and muscle weakness.
  • To correlate pulmonary function with clinical disability scales in PD patients.

Main Methods:

  • Spirography and maximal static mouth pressures were used to assess pulmonary function in 31 PD patients.
  • Flow-volume curves were analyzed to detect patterns indicative of obstruction or muscle weakness.

Related Experiment Videos

  • Clinical disability was assessed using Hoehn and Yahr, Northwestern University Disability Scale, and Webster scales.

    • Main Results:

    • Patients showed significantly reduced peak inspiratory/expiratory flow and maximal expiratory flow at 50%.
    • Maximal static mouth pressures were also significantly below normal values.
    • Nine patients exhibited signs of upper airway obstruction (UAO); flow-volume curve patterns suggested UAO and/or decreased muscle strength.

    Conclusions:

    • A significant proportion of Parkinson's disease patients exhibit subclinical upper airway obstruction and decreased effective muscle strength.
    • Pulmonary function tests can reveal respiratory impairments even in PD patients without apparent respiratory symptoms.
    • These subclinical findings underscore the importance of early respiratory evaluation and intervention in Parkinson's disease management.